With the tests of The coronavirus vaccine of the brand and Synovac Biotech Ltd. in Turkey indicates that the shot is 90% safe on both sides, yet there is no final assessment of how effective it is in protecting people against Covid-19. According to a person familiar with the trial, …
Read More »Virus Outbreak: News and Analysis from 21 December
We are keeping track of the latest coronavirus outbreaks and the global response. Sign up here for our daily newsletter on what you need to know. European countries As the travel links were suspended As part of Prime Minister Boris Johnson’s efforts to end the coronavirus mutation, a complete lockdown …
Read More »Johnson & Johnson to begin a fax trial with 60,000 people in September
A Johnson & Johnson building is on display in Irvine, California. Mike Blake | Reuters Johnson & Johnson are planning to begin what would be the biggest, in the late-stage trial testing a potential coronavirus vaccine in September, the company confirmed Thursday. The phase three trial would enroll up to …
Read More »Vaccine against Coronavirus with 50% effectiveness would be ‘game changer’
A coronavirus vaccine that is safe and at least 50% effective would be a “game changer” in the fight against the pandemic, according to a doctor who serves as a researcher for Moderna’s clinical trials. “Developing vaccines against respiratory viruses is incredibly difficult. If you think about the flu vaccine …
Read More »Coronavirus vaccine developer CureVac raises $ 213 million in IPO
An employee of the German biopharmaceutical company CureVac, demonstrates research into a vaccine for coronavirus (COVID-19) at a laboratory in Tuebingen, Germany, March 12, 2020. Andreas Gebert | REUTERS CureVac raised $ 213 million in its initial public offering (IPO) in New York on Thursday, said a person familiar with …
Read More »